BRIEF-Aerie Pharma's Roclatan succeeds in second late-stage study
* Aerie pharmaceuticals reports positive roclatan™ (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% phase 3 topline efficacy results
Dec 2 Celanese Corp
* Celanese announces Paraformaldehyde price increase
* Celanese Corp says price increase of $0.035/lb will be effective Dec. 15, 2016 Source text for Eikon: Further company coverage:
NEW YORK, May 24 U.S. stocks ended up slightly on Wednesday, with the S&P 500 hitting a record high close, after minutes of the Federal Reserve's latest meeting showed policymakers view a rate hike coming soon.